Clinical Trial Update: Pegylated Liposomal Doxorubicin Containing Chemotherapy in the Treatment of Older Non-Hodgkin's Lymphoma Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pegylated liposomal doxorubicin in older adults with Non-Hodgkin lymphoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Pegylated liposomal doxorubicin (pegylated liposomal doxorubicin)

Snippet

Sponsor: Geriatric Oncology Consortium | Conditions: Non-Hodgkin's Lymphoma | Phase 2 | Status: TERMINATED